Coelenterazine-Utilizing Luciferases with Stable Glow-Type Light Emission, Increased Substrate Affinity, Suppresed Product Inhibition, and Modulated Emission Wavelengths, and Methods of Producing and Using Thereof

Authors

Toul, M., Smith, A., Marek, M., Pinto, J. G., Planas-Iglesias, J., Pluskal, D., Vasina, M., Bednar, D., Prokop, Z., Damborsky, J.

Applicant

Masaryk University, Žerotínovo nám. 9, 601 77 Brno, Czech Republic

Application number

WO/2023/021023

Date of submission

2021-08-16

Date of publication

2023-02-23

Abstract

The present invention relates to modified protein sequences of coelenterazine-utilizing Renilla-type luciferases exhibiting stable glow-type light emission, high substrate affinity, low product inhibition factor, and modulated emission maximum, and the production and use of thereof as bioluminescent reporters and bioimaging agents.

Full application EN

Citation

Toul, M., Smith, A., Marek, M., Pinto, J. G., Planas-Iglesias, J., Pluskal, D., Vasina, M., Bednar, D., Prokop, Z., Damborsky, J., 2023: Coelenterazine-Utilizing Luciferases with Stable Glow-Type Light Emission, Increased Substrate Affinity, Suppresed Product Inhibition, and Modulated Emission Wavelengths, and Methods of Producing and Using Thereof. Masaryk University, Brno, Czech Republic. Patent WO/2023/021023.

Pavel Earns a Doctoral Degree
Poster Award at RCX Doctoral Conference
National SOC Success for Monika and Amalie
Summer Starts with Beach Volleyball!
Dr. & Dr. Party
Success at ISBC & ISLS 2026 in Thailand
Martin Received Dean’s Award